Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q2- Text added to 2017 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
abbreviated, AccuBreak, acid, ADCC, addressing, adult, age, aging, al, alternative, AML, antagonist, Anthony, anthracycline, antiemetic, area, attainment, attention, autoimmune, award, awarded, barrier, bi, bilayered, binding, biologic, bipolar, bottom, brain, Brainard, break, broadly, capable, carbamazepine, Cataldo, cellular, central, CEO, CFO, chairman, channel, chemotherapy, cholinergic, Cholinesterase, chronic, classified, CMO, cognition, cognitive, comfort, commonly, compliance, confusion, consummation, core, costly, coverage, crosslinker, cumulative, cytarabine, cytokine, declared, deep, deeply, degree, delirium, dementia, diagnosed, diarrhea, disability, discomfort, disorder, dysfunction, earned, easy, elderly, employ, encouraging, endocytic, entitled, epilepsy, equivalent, estate, ethnic, exact, executory, exploited, FASB, faster, field, found, founder, fourth, fractionation, fragment, frontline, gastrointestinal, gated, gemtuzumab, GI, Gil, good, greater, Gresham, GTBP, guidance, gut, hearing, hematopoietic, hereinafter, higher, Howard, incipient, IND, inexpensive, innate, involuntarily, involuntary, iv, junction, Kathleen, Kay, largely, layer, lectin, leukemic, lineage, listed, low, marker, MCI, MD, MDS, mechanical, member, memory, men, mental, Merger, Mestinon, mild, minimal, muscarinic, muscle, muscular, myelodysplastic, myeloid, National, nausea, neostigmine, neuromuscular, Nightingale, North, older, overcome, ownership, OXS, PainBrake, Parrott, partial, patch, Peak, penetrating, people, perception, PhD, poorly, population, portfolio, prevalence, prevalent, prone, Prostigmine, Provisional, PTO, published, pyridostigmine, Raymond, real, region, relief, remission, rent, repurposing, requested, resigned, safe, safer, schedule, Scop, scopolamine, scored, scoring, sedation, Seo, sialic, side, Siegel, single, Society, sodium, somnolence, source, stability, standpoint, stem, Steven, stimulating, store, streamlined, Stroke, study, surveillance, syndrome, tablet, Tegretol, Territory, tolerability, tolerated, top, toxicology, Transderm, transmembrane, true, typically, underway, undetected, unmet, Urbanski, vestibular, viewed, vomiting, vote, voting, Washington, Weldon, women, Yawn, Zakrzewska
Removed:
Aaion, arising, biopharmaceutical, breach, bring, broad, combining, commercializing, consistent, detachable, directed, discrimination, diseased, feature, finally, firm, holding, lawsuit, Los, model, monoclonal, participated, professional, range, recurring, remeasured, sensitive, settled, subsidiary, Superior, targeting, tissue, TNBC, tort, unique, wholly
Valuein 2017 Q2 filing- Value in 2017 Q3 filing
Original filings
Filing view